Health-related quality of life in stage III melanoma patients treated with neoadjuvant ipilimumab and nivolumab: Week 60 update of the PRADO trial

Authors :: Van Den Heuvel, N. M. J.
Reijers, I. L. M.
Versluis, J. M.
Rozeman, E. A.
Saw, R. P. M.
Blommers, K. H.
Jozwiak, K.
Suijkerbuijk, K.
Kapiteijn, E.
Van der Veldt, A. A. M.
Hospers, G. A.
Spillane, A. J.
Pennington, T. E.
Wouters, M. W. J. M.
Menzies, A. M.
van Akkooi, A. C. J.
Van De Poll-Franse, L. V.
Long, G. V.
Blank, C. U.
Boekhout, A. H.
Guided Treatment in Optimal Selected Cancer Patients (GUTS)
Source :: Annals of Oncology, 32, S1100-S1100. Oxford University Press
Publication Year :: 2021

Tools